Alvotech
Yahoo Finance • 9 days ago
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shareholder rights firm Hagens Berman is scrutinizing Icelandic biopharmaceutical company Alvotech (NASDAQ: ALVO) over the propriety of its disclosures regarding its lead drug candidate an... Full story
Yahoo Finance • 9 days ago
European Commission Approves Alvotech's AVT03 As A Biosimilar To Prolia And Xgeva
(RTTNews) - Alvotech (ALVO) announced that the European Commission has approved AVT03, a biosimilar to Amgen's Prolia and Xgeva for use across Europe. Prolia is indicated to treat osteoporosis and bone loss in postmenopausal women and in... Full story
Yahoo Finance • 9 days ago
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Com... Full story
Yahoo Finance • 9 days ago
Markaðsleyfi veitt á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu Alvotech við líftæknilyfin Prolia og Xgeva
REYKJAVÍK, 25. NÓVEMBER 2025 - Alvotech (NASDAQ: ALVO) tilkynnti í dag að Framkvæmdastjórn Evrópusambandsins hafi veitt markaðsleyfi á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu við líftæknilyfin Prolia og Xgeva, sem bæði innihalda vi... Full story
Yahoo Finance • 11 days ago
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell, Beyond Meat, Alvotech, and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Regencell Bioscience Holdings Limited (NASDAQ:RGC), Beyond Meat, Inc.... Full story
Yahoo Finance • 21 days ago
Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the Firm
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Regencell Bioscience Holdings Limited (NASDAQ:RGC), Beyond Meat, Inc.... Full story
Yahoo Finance • 21 days ago
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine months compared to the same period last ye... Full story
Yahoo Finance • 21 days ago
Alvotech kynnir uppgjör fyrstu níu mánaða ársins 2025 og helstu áfanga í rekstri félagsins
Heildartekjur á fyrstu níu mánuðum ársins voru 420 milljónir dollara, sem er 24% aukning frá sama tímabili í fyrraTekjur af sölu vöru og þjónustu á fyrstu níu mánuðum ársins voru 237 milljónir dollara, sem er 85% aukning frá sama tímabili... Full story
Yahoo Finance • 23 days ago
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation into Alvotech (NASDAQ: ALVO)
NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Alvotech (the “Company”) (NASDAQ: ALVO) or certain of its officers... Full story
Yahoo Finance • 23 days ago
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)
REYKJAVIK, Iceland, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the outcome of expedi... Full story
Yahoo Finance • 23 days ago
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)
REYKJAVIK, ICELAND (November 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the outcome of expedited infringemen... Full story
Yahoo Finance • 23 days ago
Alvotech vinnur sigur í mikilvægu dómsmáli um framleiðslu og markaðssetningu AVT06 hliðstæðunnar við Eylea (aflibercept)
Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að dómstóll í Bretlandi hafi hafnað lögbannskröfu Regeneron Pharmaceuticals og Bayer sem beindist að Alvotech og þjónustuaðila félagsins í Bretlandi. Dómstóllinn hafnaði lögbannskröfunni se... Full story
Yahoo Finance • 26 days ago
ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Alvotech (ALVO) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in AlvoTech and would like to di... Full story
Yahoo Finance • 27 days ago
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Alvotech (NASDAQ: ALVO)
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Alvotech (the “Company”) (NASDAQ: ALVO) or certain of its officers... Full story
Yahoo Finance • 27 days ago
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
REYKJAVIK, Iceland and LONDON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Li... Full story
Yahoo Finance • 29 days ago
Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO). The investigation concerns whether the Company may have viola... Full story
Yahoo Finance • 29 days ago
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
REYKJAVIK, ICELAND (November 4, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results... Full story
Yahoo Finance • 29 days ago
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekstri félagsins þann 13. nóvember nk.
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrstu níu mánaða ársins 2025 eftir lokun markaða í Bandaríkjunum, miðvikudaginn 12. nóvember nk. Fundur til kynningar á uppgjörinu verður sendur út í beinu streymi og hefst kl.... Full story
Yahoo Finance • 30 days ago
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook
[Scientist analyze biochemical samples in advanced scientific laboratory. Medical professional use microscope look microbiological developmental of viral. Biotechnology research in science lab.] Alvotech (ALVO [https://seekingalpha.com/sy... Full story
Yahoo Finance • 30 days ago
Biggest stock movers Monday: BRK.A, NIO, and more
[Technical Price Chart Data Analysis Showing 2020 Corona Virus Covid-19 Stock Market Crash] _ultraforma_/iStock via Getty Images Stock futures edged up in the premarket session on Monday, the first trading day of November, as investors st... Full story
